Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial. - Gögenur I; Justesen TF; Tarpgaard LS; Bulut M; Hansen TF; Jensen LH; Rahr HB; Gögenur M; Kirkegaard T; Balsevicius L; Chieng M; Raskov H; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2026)